4.5 Article

CONTRAST AGENT KINETICS IN THE RABBIT BRAIN DURING EXPOSURE TO THERAPEUTIC ULTRASOUND

期刊

ULTRASOUND IN MEDICINE AND BIOLOGY
卷 36, 期 6, 页码 916-924

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ultrasmedbio.2010.03.005

关键词

Ultrasound; Microbubbles; Drug delivery; Blood-brain barrier

资金

  1. National Institutes of Health [R33EB000705]
  2. Terry Fox Foundation
  3. CRC program
  4. Sunnybrook Research Institute

向作者/读者索取更多资源

Ultrasound-stimulated microbubbles are currently under investigation as a means of transiently disrupting the blood-brain barrier (BBB) and it has been shown that the strength of this effect is highly dependent on ultrasound exposure conditions. The objective of this study was to investigate the potential for contrast agent destruction in the brain under conditions relevant to BBB disruption with a view to determining its possible influence on effective exposure parameters. An ultrasound imaging array was mounted within the aperture of a 1.68-MHz focused therapy transducer. Pulse lengths of 10 ms were used at repetition rates of 0.1-2.0 Hz and pressures from 0.30-0.88MPa. Contrast imaging was performed after the bolus injection of Definity (TM), and contrast time-intensity curves were then analyzed for regions-of-interest exposed to the therapy beam. Individual therapy pulses resulted in microbubble destruction, with the degree of agent depletion and replenishment time increasing with transmit pressure. As the pulse repetition rate was increased, agent reperfusion between pulses was incomplete and the concentration within the beam was progressively diminished, to a degree dependent on both pressure and repetition rates. These results demonstrate that microbubble concentration can be substantially influenced by destruction induced by therapeutic ultrasound pulses. The kinetics of this effect may therefore be a significant factor influencing the efficiency of BBB disruption, suggesting that monitoring of the spatial and temporal distribution of contrast agents may be warranted to guide and optimize BBB disruption therapy in both preclinical and clinical contexts. (E-mail: goertz@sri.utoronto.ca) (C) 2010 World Federation for Ultrasound in Medicine & Biology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据